CYCLOBENZAPRINE TREATMENT FOR AGITATION, PSYCHOSIS AND COGNITIVE DECLINE IN DEMENTIA AND NEURODEGENERATIVE CONDITIONS

Compositions comprising cyclobenzaprine, and methods for the treatment or prevention of agitation, psychosis and/or cognitive decline and associated symptoms thereof in dementia and other neurodegenerative conditions.

Saved in:
Bibliographic Details
Main Authors Harris, Herbert W, Lederman, Seth
Format Patent
LanguageEnglish
Published 13.06.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Compositions comprising cyclobenzaprine, and methods for the treatment or prevention of agitation, psychosis and/or cognitive decline and associated symptoms thereof in dementia and other neurodegenerative conditions.
Bibliography:Application Number: US201816215952